Current Management of GISTs

Clinical Advances in Hematology and Oncology

Volumn 8, Issue 5, 2010, Pages 334-

  Blanke, Charles ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; PROTEIN TYROSINE KINASE INHIBITOR; SUNITINIB; ANTINEOPLASTIC AGENT; BENZAMIDE DERIVATIVE; INDOLE DERIVATIVE; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CLINICAL TRIAL; DRUG EFFICACY; GASTROINTESTINAL STROMAL TUMOR; HEALTH CARE QUALITY; HIGH RISK PATIENT; HUMAN; METASTASIS; PATIENT CARE; PATIENT SAFETY; POSTOPERATIVE CARE; QUALITY OF LIFE; RECURRENT CANCER; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; ADJUVANT CHEMOTHERAPY; GASTROINTESTINAL STROMAL TUMORS;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; GASTROINTESTINAL STROMAL TUMORS; HUMANS; INDOLES; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; PYRROLES; BENZAMIDES;

EID: 77953677494     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Sepe PS, Brugge WR. A guide for the diagnosis and management of gastrointestinal stromal cell tumors. Nat Rev Gastroenterol Hepatol. 2009;6:363-371.
2. Steigen SE, Eide TJ. Gastrointestinal stromal tumors (GISTs): a review. APMIS. 2009;117:73-86.
3. Blackstein ME, Corless CL, Ballman KV, et al. Risk assessment for tumor recurrence after surgical resection of localized primary gastrointestinal stromal tumor (GIST): North American Intergroup phase III trial ACOSOG Z9001. Paper presented at: American Society of Clinical Oncology 2010 Gastrointestinal Cancers Symposium. January 22-24, 2010; Orlando, FL.